46 research outputs found
Ultrafast band-gap renormalization and build-up of optical gain in monolayer MoTe
The dynamics of band-gap renormalization and gain build-up in monolayer
MoTe is investigated by evaluating the non-equilibrium Dirac-Bloch
equations with the incoherent carrier-carrier and carrier-phonon scattering
treated via quantum-Boltzmann type scattering equations. For the case where an
approximately fs-long high intensity optical pulse generates
charge-carrier densities in the gain regime, the strong Coulomb coupling leads
to a relaxation of excited carriers on a few fs time scale. The pump-pulse
generation of excited carriers induces a large band-gap renormalization during
the time scale of the pulse. Efficient phonon coupling leads to a subsequent
carrier thermalization within a few ps, which defines the time scale for the
optical gain build-up energetically close to the low-density exciton resonance.Comment: This is a post-peer-review version of an article published in
Physical Review
Recommended from our members
Carrier dynamics in TMDCs for optical applications
Fully microscopic many-body models based on the Dirac-Bloch equations and quantum-Boltzmann type scattering equations are used to study the carrier dynamics in monolayer transition metal dichalcogenides (TMDCs) under conditions as typical for applications as lasers, diodes or saturable absorbers. The carrier-carrier scattering is shown to be happening on an ultra-fast few-femtosecond timescale for excitations high above the bandgap. Once the carriers have relaxed into quasi-equilibrium distributions near the bandgap, the scattering is slowed dramatically by phase-space filling and screening of the Coulomb interaction. Here, the scatterings and resulting dephasing of the optical polarizations happen on a 100fs timescale and lead to similar broadenings as found in conventional III-V semiconductor materials. Also like the case in III-V materials, the carrier phonon scattering times are found to be in the picosecond range. The scatterings are shown to allow for gain spectra as needed for good lasing operation. It is shown that the weak interaction between the two bands associated with the two different sub-lattices can potentially allow for simultaneous lasing at two different frequencies. Strong absorption and ultrafast carrier relaxation could allow for TMDCs to be used in saturable absorption applications.Air Force Office of Scientific Research [FA9550-17-1-0246]This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
BACKGROUND: Metastatic melanoma is still one of the most prevalent skin cancers, which upon progression has neither a prognostic marker nor a specific and lasting treatment. Proteomic analysis is a versatile approach with high throughput data and results that can be used for characterizing tissue samples. However, such analysis is hampered by the complexity of the disease, heterogeneity of patients, tumors, and samples themselves. With the long term aim of quest for better diagnostics biomarkers, as well as predictive and prognostic markers, we focused on relating high resolution proteomics data to careful histopathological evaluation of the tumor samples and patient survival information. PATIENTS AND METHODS: Regional lymph node metastases obtained from ten patients with metastatic melanoma (stage III) were analyzed by histopathology and proteomics using mass spectrometry. Out of the ten patients, six had clinical follow-up data. The protein deep mining mass spectrometry data was related to the histopathology tumor tissue sections adjacent to the area used for deep-mining. Clinical follow-up data provided information on disease progression which could be linked to protein expression aiming to identify tissue-based specific protein markers for metastatic melanoma and prognostic factors for prediction of progression of stage III disease. RESULTS: In this feasibility study, several proteins were identified that positively correlated to tumor tissue content including IF6, ARF4, MUC18, UBC12, CSPG4, PCNA, PMEL and MAGD2. The study also identified MYC, HNF4A and TGFB1 as top upstream regulators correlating to tumor tissue content. Other proteins were inversely correlated to tumor tissue content, the most significant being; TENX, EHD2, ZA2G, AOC3, FETUA and THRB. A number of proteins were significantly related to clinical outcome, among these, HEXB, PKM and GPNMB stood out, as hallmarks of processes involved in progression from stage III to stage IV disease and poor survival. CONCLUSION: In this feasibility study, promising results show the feasibility of relating proteomics to histopathology and clinical outcome, and insight thus can be gained into the molecular processes driving the disease. The combined analysis of histological features including the sample cellular composition with protein expression of each metastasis enabled the identification of novel, differentially expressed proteins. Further studies are necessary to determine whether these putative biomarkers can be utilized in diagnostics and prognostic prediction of metastatic melanoma